Activation of mesangial cells by platelets in systemic lupus erythematosus via a CD154-dependent induction of CD40

Henn, 1998, CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells, Nature, 391, 591, 10.1038/35393 Slupsky, 1998, Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40, Thromb Haemost, 80, 1008, 10.1055/s-0037-1615402 Karmann, 1995, CD40 on human endothelial cells: Inducibility by cytokines and functional regulation of adhesion molecule expression, Proc Natl Acad Sci USA, 92, 4342, 10.1073/pnas.92.10.4342 Dechanet, 1997, CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells, J Immunol, 159, 5640, 10.4049/jimmunol.159.11.5640 Hollenbaugh, 1995, Expression of functional CD40 by vascular endothelial cells, J Exp Med, 182, 33, 10.1084/jem.182.1.33 Van KOOTEN, 2000, Immunological function of tubular epithelial cells: The functional implications of CD40 expression, Exp Nephrol, 8, 203, 10.1159/000020669 Tanaka, 2002, Human platelets stimulate mesangial cells to produce monocyte chemoattractant protein-1 via the CD40/CD40 ligand pathway and may amplify glomerular injury, J Am Soc Nephrol, 13, 2488, 10.1097/01.ASN.0000029588.07166.20 Cameron, 1999, Lupus nephritis, J Am Soc Nephrol, 10, 413, 10.1681/ASN.V102413 Berden, 1999, Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis, Curr Opin Nephrol Hypertens, 8, 299, 10.1097/00041552-199905000-00005 Clark, 1976, The platelet as a mediator of tissue damage in immune complex glomerulonephritis, Clin Nephrol, 6, 287 Clark, 1975, Intrarenal platelet consumption in the diffuse proliferative nephritis of systemic lupus erythematosus, Clin Sci Mol Med, 49, 247 Allford, 2000, Current understanding of the pathophysiology of thrombotic thrombocytopenic purpura, J Clin Pathol, 53, 497, 10.1136/jcp.53.7.497 Abboud, 1995, Role of platelet-derived growth factor in renal injury, Annu Rev Physiol, 57, 297, 10.1146/annurev.ph.57.030195.001501 Perico, 1990, Role of platelet-activating factor in renal immune injury and proteinuria, Am J Nephrol, 10, S98, 10.1159/000168202 Camussi, 1986, Localization of cationic proteins derived from platelets and polymorphonuclear neutrophils and local loss of anionic sites in glomeruli of rabbits with experimentally-induced acute serum sickness, Lab Invest, 55, 56 Camussi, 1986, Potential role of platelet-activating factor in renal pathophysiology, Kidney Int, 29, 469, 10.1038/ki.1986.23 Johnson, 1987, Participation of the myeloperoxidase-H2O2-halide system in immune complex nephritis, Kidney Int, 32, 342, 10.1038/ki.1987.215 Parbtani, 1980, Platelet and plasma serotonin in glomerulonephritis. III: The nephritis of systemic lupus erythematosus, Clin Nephrol, 14, 164 Zoja, 1995, Role of platelets in progressive glomerular diseases, Pediatr Nephrol, 9, 495, 10.1007/BF00866739 Wu, 1993, Platelets and neutrophils are critical to the enhanced glomerular arachidonate metabolism in acute nephrotoxic nephritis in rats, J Clin Invest, 91, 766, 10.1172/JCI116295 Johnson, 1988, Platelets mediate neutrophil-dependent immune complex nephritis in the rat, J Clin Invest, 82, 1225, 10.1172/JCI113720 Ogawa, 1982, Effects of various antiplatelet drugs and defibrinating agent on experimental glomerulonephritis in rats, J Lab Clin Med, 99, 428 Izumino, 1987, Effect of the antiplatelet agents ticlopidine and dipyridamole on nephrotoxic serum nephritis in rats, Nephron, 45, 306, 10.1159/000184169 Tan, 1982, The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 25, 1271, 10.1002/art.1780251101 Dubus, 2002, Mycophenolic acid antagonizes the activation of cultured human mesangial cells, Kidney Int, 62, 857, 10.1046/j.1523-1755.2002.00514.x Pasquet, 2002, Evidence that the platelet integrin alphaIIb beta3 is regulated by the integrin-linked kinase, ILK, in a PI3-kinase dependent pathway, Thromb Haemost, 88, 115, 10.1055/s-0037-1613163 Hermann, 2001, Platelet CD40 ligand (CD40L)—Subcellular localization, regulation of expression, and inhibition by clopidogrel, Platelets, 12, 74, 10.1080/09537100020031207 Nannizzi-ALAIMO, 2003, Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation, Circulation, 107, 1123, 10.1161/01.CIR.0000053559.46158.AD Van KOOTEN, 1994, B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40, Eur J Immunol, 24, 787, 10.1002/eji.1830240402 Contin, 2003, Membrane-anchored CD40 is processed by the tumor necrosis factor-alpha-converting enzyme. Implications for CD40 signaling, J Biol Chem, 278, 32801, 10.1074/jbc.M209993200 Nguyen, 2000, Involvement of STAT-1 and ets family members in interferon-gamma induction of CD40 transcription in microglia/macrophages, J Biol Chem, 275, 23674, 10.1074/jbc.M002482200 Alderson, 1993, CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40, J Exp Med, 178, 669, 10.1084/jem.178.2.669 Krzesz, 1999, Cytokine-inducible CD40 gene expression in vascular smooth muscle cells is mediated by nuclear factor kappaB and signal transducer and activation of transcription-1, FEBS Lett, 453, 191, 10.1016/S0014-5793(99)00683-3 Kuroiwa, 1999, CD40 ligand-activated human monocytes amplify glomerular inflammatory responses through soluble and cell-to-cell contact-dependent mechanisms, J Immunol, 163, 2168, 10.4049/jimmunol.163.4.2168 Schwarting, 1998, IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice, J Immunol, 161, 494, 10.4049/jimmunol.161.1.494 Kuroiwa, 1998, Cellular interactions in the pathogenesis of lupus nephritis: The role of T cells and macrophages in the amplification of the inflammatory process in the kidney, Lupus, 7, 597, 10.1191/096120398678920712 Kato, 1999, The soluble CD40 ligand sCD154 in systemic lupus erythematosus, J Clin Invest, 104, 947, 10.1172/JCI7014 Henn, 2001, The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40, Blood, 98, 1047, 10.1182/blood.V98.4.1047 May, 2002, Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells, Circulation, 106, 2111, 10.1161/01.CIR.0000033597.45947.0F Camussi, 1994, Interactive effects of tumor necrosis factor and platelet-activating factor in the pathogenesis of glomerular injury, Lab Invest, 70, 435 Colasanti, 1987, Deposition of fibrin-stabilizing factor (F XIIIA and S), fibrinogen-related antigens, fibrinogen degradation products (FDPd and FDPe) and antihemolytic factor (F VIII) in renal disease: analysis of 161 cases by immunofluorescence microscopy, Clin Nephrol, 28, 28 Mccutcheon, 1993, Fibrin deposition in SLE glomerulonephritis, Lupus, 2, 99, 10.1177/096120339300200206 Takemura, 1987, Glomerular deposition of cross-linked fibrin in human kidney diseases, Kidney Int, 32, 102, 10.1038/ki.1987.178 Camussi, 1986, Platelet cationic proteins are present in glomeruli of lupus nephritis patients, Kidney Int, 30, 555, 10.1038/ki.1986.221 Nagahama, 2001, Platelet activation markers and soluble adhesion molecules in patients with systemic lupus erythematosus, Autoimmunity, 33, 85, 10.3109/08916930108995993 Joseph, 2001, Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis, Br J Haematol, 115, 451, 10.1046/j.1365-2141.2001.03101.x Latta, 1992, An approach to the structure and function of the glomerular mesangium, J Am Soc Nephrol, 2, S65, 10.1681/ASN.V210s65 Alexopoulos, 1990, Lupus nephritis: Correlation of interstitial cells with glomerular function, Kidney Int, 37, 100, 10.1038/ki.1990.14 Ootaka, 1997, Mechanism of infiltration and activation of glomerular monocytes/macrophages in IgA nephropathy, Am J Nephrol, 17, 137, 10.1159/000169087 Brady, 1993, Leukocyte adhesion molecules: Potential targets for therapeutic intervention in kidney diseases, Curr Opin Nephrol Hypertens, 2, 171, 10.1097/00041552-199303000-00001 Nikolic-PATERSON, 1994, Macrophages in renal injury, Kidney Int (Suppl), 45, S79 Lowenhaupt, 1982, A quantitative method to measure human platelet chemotaxis using indium-111-oxine-labeled gel-filtered platelets, Blood, 60, 1345, 10.1182/blood.V60.6.1345.1345 Border, 1992, Antagonists of transforming growth factor-beta: A novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosis, Kidney Int, 41, 566, 10.1038/ki.1992.83 Border, 1990, Transforming growth factor-beta regulates production of proteoglycans by mesangial cells, Kidney Int, 37, 689, 10.1038/ki.1990.35 Okuda, 1990, Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix, J Clin Invest, 86, 453, 10.1172/JCI114731 Contin, 2003, Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients, Immunology, 110, 131, 10.1046/j.1365-2567.2003.01716.x Schwabe, 1999, Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patients, Clin Exp Immunol, 117, 153, 10.1046/j.1365-2249.1999.00935.x Uhm, 2003, Cytokine balance in kidney tissue from lupus nephritis patients, Rheumatology, 42, 935, 10.1093/rheumatology/keg255 Yellin, 1997, Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides, Arthritis Rheum, 40, 124, 10.1002/art.1780400117 Van KOOTEN, 1999, Synergistic effect of interleukin-1 and CD40L on the activation of human renal tubular epithelial cells, Kidney Int, 56, 41, 10.1046/j.1523-1755.1999.00514.x Kairaitis, 2003, Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal disease, Kidney Int, 64, 1265, 10.1046/j.1523-1755.2003.00223.x Kalled, 1998, Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function, J Immunol, 160, 2158, 10.4049/jimmunol.160.5.2158